Cargando…
Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes
Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986604/ https://www.ncbi.nlm.nih.gov/pubmed/33305354 http://dx.doi.org/10.1002/path.5601 |
_version_ | 1783668475090173952 |
---|---|
author | Ramirez‐Moral, Ivan Blok, Dana C Bernink, Jochem H Garcia‐Laorden, M Isabel Florquin, Sandrine Boon, Louis van't Veer, Cornelis Mack, Matthias Saluzzo, Simona Knapp, Sylvia Spits, Hergen de Vos, Alex F van der Poll, Tom |
author_facet | Ramirez‐Moral, Ivan Blok, Dana C Bernink, Jochem H Garcia‐Laorden, M Isabel Florquin, Sandrine Boon, Louis van't Veer, Cornelis Mack, Matthias Saluzzo, Simona Knapp, Sylvia Spits, Hergen de Vos, Alex F van der Poll, Tom |
author_sort | Ramirez‐Moral, Ivan |
collection | PubMed |
description | Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We sought here to determine the effect of recombinant IL‐33 on the host response during murine pneumonia caused by the common Gram‐negative pathogen Klebsiella pneumoniae. IL‐33 pretreatment prolonged survival for more than 1 day during lethal airway infection and decreased bacterial loads at the primary site of infection and distant organs. Postponed treatment with IL‐33 (3 h) also reduced bacterial growth and dissemination. IL‐33‐mediated protection was not observed in mice deficient for the IL‐33 receptor component IL‐1 receptor‐like 1. IL‐33 induced a brisk type 2 response, characterized by recruitment of type 2 innate lymphoid cells to the lungs and enhanced release of IL‐5 and IL‐13. However, neither absence of innate lymphoid cells or IL‐13, nor blocking of IL‐5 impacted on IL‐33 effects in mice infected with Klebsiella. Likewise, IL‐33 remained effective in reducing bacterial loads in mice lacking B, T, and natural killer T cells. Experiments using antibody‐mediated cell depletion indicated that neutrophils and inflammatory monocytes were of importance for antibacterial defense. The capacity of IL‐33 to restrict bacterial growth in the lungs was strongly reduced in mice depleted of both neutrophils and inflammatory monocytes, but not in mice selectively depleted of either one of these cell types. These results suggest that IL‐33 boosts host defense during bacterial pneumonia by a combined effect on neutrophils and inflammatory monocytes. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-7986604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-79866042021-03-25 Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes Ramirez‐Moral, Ivan Blok, Dana C Bernink, Jochem H Garcia‐Laorden, M Isabel Florquin, Sandrine Boon, Louis van't Veer, Cornelis Mack, Matthias Saluzzo, Simona Knapp, Sylvia Spits, Hergen de Vos, Alex F van der Poll, Tom J Pathol Original Papers Pneumonia represents a major health care burden and Gram‐negative bacteria provide an increasing therapeutic challenge at least in part through the emergence of multidrug‐resistant strains. IL‐33 is a multifunctional cytokine belonging to the IL‐1 family that can affect many different cell types. We sought here to determine the effect of recombinant IL‐33 on the host response during murine pneumonia caused by the common Gram‐negative pathogen Klebsiella pneumoniae. IL‐33 pretreatment prolonged survival for more than 1 day during lethal airway infection and decreased bacterial loads at the primary site of infection and distant organs. Postponed treatment with IL‐33 (3 h) also reduced bacterial growth and dissemination. IL‐33‐mediated protection was not observed in mice deficient for the IL‐33 receptor component IL‐1 receptor‐like 1. IL‐33 induced a brisk type 2 response, characterized by recruitment of type 2 innate lymphoid cells to the lungs and enhanced release of IL‐5 and IL‐13. However, neither absence of innate lymphoid cells or IL‐13, nor blocking of IL‐5 impacted on IL‐33 effects in mice infected with Klebsiella. Likewise, IL‐33 remained effective in reducing bacterial loads in mice lacking B, T, and natural killer T cells. Experiments using antibody‐mediated cell depletion indicated that neutrophils and inflammatory monocytes were of importance for antibacterial defense. The capacity of IL‐33 to restrict bacterial growth in the lungs was strongly reduced in mice depleted of both neutrophils and inflammatory monocytes, but not in mice selectively depleted of either one of these cell types. These results suggest that IL‐33 boosts host defense during bacterial pneumonia by a combined effect on neutrophils and inflammatory monocytes. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2021-01-19 2021-04 /pmc/articles/PMC7986604/ /pubmed/33305354 http://dx.doi.org/10.1002/path.5601 Text en © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Papers Ramirez‐Moral, Ivan Blok, Dana C Bernink, Jochem H Garcia‐Laorden, M Isabel Florquin, Sandrine Boon, Louis van't Veer, Cornelis Mack, Matthias Saluzzo, Simona Knapp, Sylvia Spits, Hergen de Vos, Alex F van der Poll, Tom Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title | Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title_full | Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title_fullStr | Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title_full_unstemmed | Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title_short | Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
title_sort | interleukin‐33 improves local immunity during gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986604/ https://www.ncbi.nlm.nih.gov/pubmed/33305354 http://dx.doi.org/10.1002/path.5601 |
work_keys_str_mv | AT ramirezmoralivan interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT blokdanac interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT berninkjochemh interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT garcialaordenmisabel interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT florquinsandrine interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT boonlouis interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT vantveercornelis interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT mackmatthias interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT saluzzosimona interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT knappsylvia interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT spitshergen interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT devosalexf interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes AT vanderpolltom interleukin33improveslocalimmunityduringgramnegativepneumoniabyacombinedeffectonneutrophilsandinflammatorymonocytes |